| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-10 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |